These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28096652)

  • 21. [Ranibizumab in the ARMD wet form of age-related macular degeneration treatment - two years results obtained from the AMADEuS Registry].
    Matušková V; Kolář P; Vysloužilová D; Vlková E; Dušek L; Kandrnal V; Jarkovský J; Uher M
    Cesk Slov Oftalmol; 2012 Nov; 68(5):171-7. PubMed ID: 23461368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A safety evaluation of ranibizumab in the treatment of age-related macular degeneration.
    Gibson JM; Gibson SJ
    Expert Opin Drug Saf; 2014 Sep; 13(9):1259-70. PubMed ID: 25091039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RANIBIZUMAB IN PIGMENT EPITHELIAL TEARS SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Prospective Study.
    Larsen PP; Oishi A; Bedar MS; Heymer PKR; Clemens CR; König S; Gutfleisch M; Pauleikhoff D; Eter N; Wolf A; Holz FG; Krohne TU
    Retina; 2019 Dec; 39(12):2369-2377. PubMed ID: 30198967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration.
    Gomi F; Sawa M; Tsujikawa M; Nishida K
    Retina; 2012 Oct; 32(9):1804-10. PubMed ID: 22718152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
    Feng L; Hu JH; Chen J; Xie X
    J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.
    Cunningham ET; Feiner L; Chung C; Tuomi L; Ehrlich JS
    Ophthalmology; 2011 Dec; 118(12):2447-52. PubMed ID: 21872935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term treatment with intravitreal ranibizumab for exudative age-related macular degeneration].
    Lukács R; Resch M; Papp A; Szabó A; Borbándy Á; Menkens H; Kiss H; Németh J
    Orv Hetil; 2013 Nov; 154(45):1790-7. PubMed ID: 24184931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year treatment outcomes following intravitreal ranibizumab injections for neovascular age-related macular degeneration in Japanese patients.
    Wada I; Oshima Y; Shiose S; Kano K; Nakao S; Kaizu Y; Yoshida S; Ishibashi T; Sonoda KH
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1411-1418. PubMed ID: 31119425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of ranibizumab combined with photodynamic therapy on wet age-related macular degeneration.
    Chen L; Wang B; Cui W; Fang S
    Exp Ther Med; 2020 Jun; 19(6):3691-3697. PubMed ID: 32346433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration.
    Park SS; Daftari I; Phillips T; Morse LS
    Retina; 2012 May; 32(5):956-66. PubMed ID: 22183743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INTRAVITREAL RANIBIZUMAB THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND THE RISK OF STROKE: A National Sample Cohort Study.
    Rim TH; Lee CS; Lee SC; Kim DW; Kim SS
    Retina; 2016 Nov; 36(11):2166-2174. PubMed ID: 27341664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration.
    Dervenis N; Younis S
    Clin Ophthalmol; 2016; 10():1117-22. PubMed ID: 27366051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration.
    Fauser S; Viebahn U; Muether PS
    Acta Ophthalmol; 2015 Dec; 93(8):734-8. PubMed ID: 26016605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Wet form age-related macular degeneration two years treatment results using anti VEGF drugs].
    Studnička J; Rencová E; Dusová J; Marák J; Burova M; Rozsíval P; Jarkovský J; Kandrnal V
    Cesk Slov Oftalmol; 2013 Aug; 69(3):96-101. PubMed ID: 24437955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INTRAVITREAL DEXAMETHASONE IMPLANT AS ADJUVANT TREATMENT FOR BEVACIZUMAB- AND RANIBIZUMAB-RESISTANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Prospective Pilot Study.
    Barikian A; Salti H; Safar A; Mahfoud ZR; Bashshur ZF
    Retina; 2017 Jul; 37(7):1337-1344. PubMed ID: 27768640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EFFECT OF INTRAVITREAL RANIBIZUMAB ON GANGLION CELL COMPLEX AND PERIPAPILLARY RETINAL NERVE FIBER LAYER IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
    Zucchiatti I; Cicinelli MV; Parodi MB; Pierro L; Gagliardi M; Accardo A; Bandello F
    Retina; 2017 Jul; 37(7):1314-1319. PubMed ID: 28574419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration.
    Regillo CD; Busbee BG; Ho AC; Ding B; Haskova Z
    Am J Ophthalmol; 2015 Nov; 160(5):1014-1023.e2. PubMed ID: 26231305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Effectiveness of Cataract Surgery with Simultaneous Intravitreal Anti-VEGF in Patients with Previously Treated Exudative Age-Related Macular Degeneration.
    Falcão MS; Freitas-Costa P; Beato JN; Pinheiro-Costa J; Rocha-Sousa A; Carneiro Â; Brandão EM; Falcão-Reis F
    Acta Med Port; 2017 Feb; 30(2):127-133. PubMed ID: 28527480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab.
    Narayan DS; Muecke J
    Indian J Ophthalmol; 2015 Nov; 63(11):832-6. PubMed ID: 26669334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting.
    Vardarinos A; Gupta N; Janjua R; Iron A; Empeslidis T; Tsaousis KT
    BMC Ophthalmol; 2017 Apr; 17(1):58. PubMed ID: 28449645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.